Perinatal Stem Cells Research and Therapy

Perinatal Stem Cells provides researchers and clinicians with a comprehensive description of the current clinical and pre-clinical applications of stem cells derived from perinatal sources, such as amniotic fluid, placenta and placental membranes, the umbilical cord and Wharton's jelly. It's compiled by leading experts in the field, offering readers detailed insights into sources of perinatal stem cells and their potential for disease treatment. Therapeutic applications of perinatal stem cells include the treatment of in utero and pregnancy related diseases, cardiac disease, liver disease, pulmonary disease, inflammatory diseases, for hematopoietic regeneration, and for neural protection after stroke or traumatic brain injury.
In addition, the rapid advance in clinical translation and commercialization of perinatal stem cell therapies is highlighted in a section on Clinical and Industry Perspective which provides insight into the new opportunities and challenges involved in this novel and exciting industry.

About the author

Anthony Atala, MD, is the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine, and the W. Boyce Professor and Chair of Urology. Dr. Atala is a practicing surgeon and a researcher in the area of regenerative medicine. Fifteen applications of technologies developed in Dr. Atala's laboratory have been used clinically. He is Editor of 25 books and 3 journals. Dr. Atala has published over 800 journal articles and has received over 250 national and international patents. Dr. Atala was elected to the Institute of Medicine of the National Academies of Sciences, to the National Academy of Inventors as a Charter Fellow, and to the American Institute for Medical and Biological Engineering.

Dr. Atala has led or served several national professional and government committees, including the National Institutes of Health working group on Cells and Developmental Biology, the National Institutes of Health Bioengineering Consortium, and the National Cancer Institute’s Advisory Board. He is a founding member of the Tissue Engineering Society, Regenerative Medicine Foundation, Regenerative Medicine Manufacturing Innovation Consortium, Regenerative Medicine Development Organization, and Regenerative Medicine Manufacturing Society.

Product details

• Assisted by: Sean Murphy (Editor), Curtis L. Cetrulo (Editor), Kyle J. Cetrulo (Editor), Anthony Atala (Editor), Rouzbeh R. Taghizadeh (Editor), Murphy Sean (Editor), Kyle J. Cetrulo (Editor), Curtis L Cetrulo (Editor), Taghizadeh Rouzbeh R. (Editor), Atala Anthony (Editor), Kyle J Cetrulo (Editor), Rouzbeh R Taghizadeh (Editor), Curtis L Cetrulo (Editor), Anthony (Department of Urology Atala (Editor), Kyle J. (Chief Executive Officer Cetrulo (Editor), Rouzbeh R. (Co-Founder Taghizadeh (Editor), Curtis L (Assistant Professor Cetrulo (Editor), Sean (Assistant Professor Murphy (Editor)
• Authors: Anthony Atala, Anthony (EDT)/ Cetrulo Atala
• Publisher: Academic Press London
• Content: Book
• Product form: Hardback
• Publication date: 31.07.2018
• Subject: Natural sciences, medicine, IT, technology > Biology > General, dictionaries
• EAN: 9780128120156
• ISBN: 978-0-12-812015-6
• Pages: 418
• Subjects: Trauma, Expansion, Regeneration, skin, Pediatric, MEDICAL / General, Child, Transplantation, Klinische und Innere Medizin, Development, SCIENCE / Life Sciences / Developmental Biology, WOUND HEALING, Stroke, SCIENCE / Life Sciences / Biochemistry, Biomedizinische Technik, SCIENCE / Life Sciences / Cell Biology, SCIENCE / Life Sciences / Biophysics, regenerative medicine, Inflammation, Chorion, Invention, CVD, Differentiation, manufacturing processes, License, heart failure, immunomodulation, Biomedical engineering, stem cells, Materno-fetal medicine, Allograft, Peripheral Artery Disease, Trophoblast, brain injury, Materno-foetal medicine / perinatology, traumatic brain injury, novelty, Cell Therapy, Stem Cell, Angiogenesis, Neurogenesis, stem cell transplantation, placenta, liver disease, clinical trial, Neural Stem Cells, hematopoietic stem cell, cardioprotection, utility, miRNA, vasculogenesis, exosomes, Mesenchymal Stem Cells, Stem Cell Therapy, autologous, Kidney disease, Stem Cell Transplant, Perinatal, Extracellular vesicles, Secretome, Amniotic fluid, umbilical cord, Biomedical engineering / Medical engineering, Neuroregeneration, Aplastic anemia, Functional Assays, cerebral ischemia, Microvesicles, Immunoregulation, Stem cell niche, Ischemic Heart Disease, Necrotizing enterocolitis, Cell-Free Therapy, Hirschsprung's disease, Adult Stem Cells, cell transplantation, Cord Blood, Endothelial progenitors, homing, Exosome, Chimerism, Multipotency, Engraftment, Pluripotency, tissue differentiation, critical limb ischemia, amnion, mesenchymal stromal cells, cell-based therapy, Conditioned medium, PLX-R18Preclinical study, Congenital metabolic disorders, Nonobviousness, Therapeutic dose, Hematopoietic syndrome of acute radiation syndrome, Stem cell dose, trophoblast stem cells, Cord tissue, Asymmetric self-renewal, Stem cell medicine, Umbilical stem cells, Myocardial renewal, Placental villi, Paracrine effect, Amniotic membrane, Cell therapeutics, Amniotic epithelial cells, Placental cell therapy, MSC priming/preconditioning, Amniotic fluid stem cells, Perinatal stem cell, PLX-PAD, Cord tissue perinatal stem cells, Perinatal MSC, Tissue variability, Cardiac progenitor cells, Stem cell count, Lateral genetic transfer, Stromacytic properties, Family bank, Amniotic mesenchymal stromal cells, Congenital disorders,In utero therapy, Heterogeneous CT-PSCs, Cellular cardiomyoplasty, dHACM, Prostaglandin E2T cells, Allogeneic banking, Between-donor variability, Tissue stem cells, paracrine, Phenotypic durability, Wharton's jelly, Cardiac repair, WJ-MSCs, Perinatal stem cells, Hypoxic ischemic injury, Prevascularization, Placenta-derived stem cells, Distributed stem cells, Umbilical Cord Blood, Renoprotection